1. Three doses help—but immunosuppressed patients remain a COVID-19 high-risk group Summary: In a systematic review and random-effects meta-analysis, Stadler and colleagues searched PubMed, Scopus, and Embase through...
1. Firearms remain America’s defining youth mortality crisis Summary: In this correspondence responding to a 2026 research letter, Bleyer, Liu, and Thomas analyzed 2024 CDC WONDER mortality data for U.S. residents aged...
1. GBS vaccine candidate clears a first key hurdle in HIV-endemic Africa A Ugandan phase 2 trial shows a hexavalent GBS6 vaccine candidate is safe and equally immunogenic in pregnant women with and without HIV, offering...
Summary This study evaluates the effectiveness of seasonal influenza vaccination in California by analyzing data from mandatory statewide public health reporting systems for influenza laboratory results and administered...
Reference Pérez Marc G, Vizzotti C, Fell DB, et al. Real-world effectiveness of RSVpreF vaccination during pregnancy against RSV-associated lower respiratory tract disease leading to hospitalisation in infants during...
The below review of recent pertussis research articles reiterates well-characterized pertussis dynamics but leave critical questions unanswered: Can mucosal vaccines outperform natural infection in blocking transmission...
A groundbreaking study led by the Perelman School of Medicine at the University of Pennsylvania reveals that unvaccinated children and adolescents were up to 20 times more likely to develop long COVID than their...
The effectiveness of vaccines plays a crucial role in public health, determining their ability to prevent infection, reduce disease severity, and limit transmission within communities. A recent study examined how well...
A new study on Chile’s national COVID-19 vaccination program, to be presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon 23-26), and published in The Lancet...
Background During the last 30 years, the number of reported TBE cases in Europe has increased by more than 193%, despite two effective TBE vaccines (FSME Immune and Encepur) being available. The raison for this increase...